The subsequent few months will nonetheless be troublesome as virus circumstances proceed to set new each day data within the U.S., an infectious illness doctor mentioned this week regardless of promising news from vaccine trials.
That’s as a result of a vaccine will not be obtainable in time to cease the flood of circumstances that’s prone to come as winter approaches within the Northern Hemisphere.
Pfizer and BioNTech on Monday announced that their coronavirus vaccine was greater than 90% efficient in stopping the illness.
“What we’re hearing and what we’re seeing is that this is promising news, but it’s not the end all, be all,” mentioned Dr. Syra Madad, senior director of the systemwide particular pathogens program at New York City Health + Hospitals.
There’s a timeline for when the vaccine will be obtainable and when it may possibly be administered, she informed CNBC’s “Street Signs Asia” on Tuesday. “There’s still some time between now and then, which means that we have some very rough few months ahead of us.”
More than 50.9 million individuals have been contaminated with the coronavirus globally, together with 10.1 million within the U.S., in keeping with information compiled by Johns Hopkins University.
Cases have spiked in latest weeks because the climate turns colder, and medical consultants have warned that the state of affairs might worsen.
Madad mentioned pharmaceutical corporations have mentioned vaccines could be obtainable by the top of 2020 for precedence teams equivalent to health-care employees, however the public will not have entry but.
“We’re not actually going to see the effectiveness of these vaccines played out in the general population until sometime (in) quarter two of next year, so we still have some months to go,” she mentioned.
“This is a process that is going to follow a pretty fast timeline, but certainly it is not fast enough, with the coming months and the increased number of cases that we’re seeing around the world.”